Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Konstantinos Voskarides practices in Nicosia, Cyprus. Voskarides is rated as an Elite expert by MediFind in the treatment of Thin Basement Membrane Nephropathy. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Thin Basement Membrane Nephropathy, Alport Syndrome, Autosomal Dominant Distal Renal Tubular Acidosis, and Distal Renal Tubular Acidosis.
Alkis Pierides practices in Nicosia, Cyprus. Pierides is rated as an Elite expert by MediFind in the treatment of Thin Basement Membrane Nephropathy. They are also highly rated in 6 other conditions, according to our data. Their top areas of expertise are Thin Basement Membrane Nephropathy, Alport Syndrome, Chronic Kidney Disease, and Focal Segmental Glomerulosclerosis.
Panayiota Demosthenous practices in Nicosia, Cyprus. Demosthenous is rated as an Elite expert by MediFind in the treatment of Thin Basement Membrane Nephropathy. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Thin Basement Membrane Nephropathy, Alport Syndrome, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD).
Summary: The hereditary type IV collagen disease Alport syndrome inevitably leads to end-stage renal disease. Currently there are no therapies known to improve outcome. Our non-interventional, observational study investigates, if medications such as ACE-inhibitors can (1) delay time to dialysis and (2) improve life-expectancy within three generations of Alport-families in Europe.
Summary: INTRODUCTION: Approximately 44% of cancer survivors experience a deteriorated quality of life 5 years after diagnosis due to late onset of complications related to cancer treatments. The objective of the study is to evaluate the incidence rates of treatment-related complications, identify sub-clinical abnormalities and risk factors in patients participating in the PASCA post-treatment program. MET...